Search

» » Valeant revenue forecast fizzles as competition heats up; shares dip

Valeant revenue forecast fizzles as competition heats up; shares dip

(Reuters) - Valeant Pharmaceuticals on Wednesday gave a weaker-than-expected revenue forecast for 2018, as several of its major drugs face more competition from generics.

Valeant revenue forecast fizzles as competition heats up; shares dip
Read More


Bagikan Berita Ini

Related Posts :

0 Response to "Valeant revenue forecast fizzles as competition heats up; shares dip"

Posting Komentar

Langganan: Posting Komentar (Atom)
Diberdayakan oleh Blogger.